Skip to main content
. 2019 May 28;42(2):657–669. doi: 10.3892/or.2019.7174

Table VI.

Tumor incidence rate during the 4-week observation period between CTRL and shCHD1L-1.

Tumor incidence rate (n/total) for week

Groups 1 2 3 4
CTRL 0/5 1/5 3/5 4/5
shCHD1L-1 0/5 0/5 1/5 2/5

CHD1L, chromodomain helicase/ATPase DNA-binding protein 1-like gene; CTRL, control.